focus -WSS

focus

author：explore 2025-10-02 00:41:45 - browse：1

close-up of psoriasis on a hand. -- biotech coverage from STAT — A close-up of psoriasis on a hand. Adobe

San Francisco startup Alumis Inc. has raised $259 million in a bid to best big pharma’s work in plaque psoriasis.

Alumis announced its Series C round Wednesday and plans to move its lead drug into Phase 3 trials. Venture firm Foresite Capital, which incubated Alumis, co-led the financing with Samsara BioCapital and venBio Partners.

Alumis’ lead drug, ESK-001, is an oral medicine designed to help patients with the most common type of psoriasis by inhibiting a signaling protein called TYK2. Research has shown that the TYK2 protein plays a role in diseases where the immune system overreacts, which has made it a popular drug target in recent years.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Biotech companies concerned about China biosecurity crackdown

knowledge

WSS

Why Marc Tessier

In search for therapies for solid tumors, companies turn to claudin

Hey, doctors: Don't be no

FogPharma raises $145 million in rare Series E round

FogPharma raises $145 million in rare Series E round

Florida babysitter arrested over hot car death, authorities say

Wikipedia

focus

Wikipedia

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

'The View' co

Apple is now the first public company to be valued at $3 trillion

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

Medicare details structure of new drug price negotiation program

Grand jury probing Trump's efforts to overturn 2020 election did not meet Friday: Sources

Trump demands the U.S. pay no more for drugs than other countries … again

A new deal aims to ramp up use of AI in rehab care decisions

The high cost of giving birth even with insurance

A Q&A with Aletha Maybank, AMA’s chief health equity officer

Wikipedia

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

Biden White House, tech companies launch new safeguards around emerging AI technology

An inside look at PIPEs, biotech's buzzy new financing tool

Clinical trials giant ICON acquires HumanFirst

What is artificial intelligence? Experts weigh in

A former Republican legislative candidate has been charged for his role in the US Capitol riot

focus

knowledge

Wikipedia

hotspot